Novak Djokovic, is a Co-founder and the majority shareholder in a firm developing a COVID-19 treatment.
The tennis star has been in the news since he was deported from Australia over his refusal to vaccinated ahead of Australia Open.
- Vaccine pass law: Djokovic could be barred from French Open
- ‘Disappointed’ Djokovic deported from Australia
QuantBioRes’ Chief executive, Ivan Loncarevic, has said the Serbian athlete owns 80% share in the Danish biotech company.
“He is one of the founders of my company; we founded in June 2020,” he said.
According to Reports from Metro.co.uk, Danish Business register shows that Djokovic and his wife Jelena are the majority shareholders at the firm, which has around 20 staff in Denmark, Slovenia, Australia and Britain.
Loncarevic further explained that the company is working on the treatment and not a vaccine.
“We aim to develop a new technology to fight viruses and resistant bacteria and we decided to use COVID as a showcase.
“If we succeed with COVID, we will succeed with other virus.”
Djokovic was described as a ‘talisman of anti-vaccination sentiment’ by Australia’s immigration minister.
Sparking controversy in summer 2020 when he hosted a Charity tennis tournament with little social distancing that led to a COVID outbreak.
